Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Charles & Colvard ( (CTHR) ) is now available.
On June 24, 2025, Charles & Colvard entered into a Convertible Secured Note Purchase Agreement with Ethara Capital LLC, resulting in a $2.0 million investment issued in two tranches, with the final closing on July 21, 2025. Additionally, the company announced changes to its board of directors, including the resignation of Ollin Sykes and the appointment of Ruten Bhanderi and James Tu, with Mr. Tu becoming the new Chairman. These changes are part of the company’s strategic alignment with Ethara Capital’s interests, potentially impacting its governance and operational strategies.
Spark’s Take on CTHR Stock
According to Spark, TipRanks’ AI Analyst, CTHR is a Neutral.
Charles & Colvard’s stock is significantly impacted by poor financial performance and valuation metrics, which are compounded by technical indicators signaling a bearish trend. While the convertible note agreement is a positive step, the Nasdaq delisting raises serious concerns about the company’s future trading prospects.
To see Spark’s full report on CTHR stock, click here.
More about Charles & Colvard
Charles & Colvard, Ltd. operates in the jewelry industry, focusing on the production and sale of lab-grown diamonds and moissanite gemstones.
Average Trading Volume: 5,987
Technical Sentiment Signal: Sell
Current Market Cap: $935.5K
For detailed information about CTHR stock, go to TipRanks’ Stock Analysis page.